Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.
The companies will also enter into a transition services agreement. Viatris will provide certain transition services, including commercialization services for an expected 2-years
Biocon said its subsidiary Biocon Pharma has received approval of its ANDA for Posaconazole Delayed-Release tablets from the US FDA.
The stock of Bandhan Bank has been underperforming the banking index and is still struggling below the resistance zone of moving averages
Pharma major makes it to the DJSI EM Index with a total sustainability score of 45 as against an industry average of 18